Nature News & Comment
The week in science: 20–26 October 2017.
Nature 550 434 doi: 10.1038/550434a
Precision tools expand the number of ‘base editors’ available for manipulating DNA and RNA.
Nature 550 439 doi: 10.1038/550439a
Aid organizations have been piloting a nimble approach to cut through the fog of war.
Nature 550 444 doi: 10.1038/550444a
Biomedical-research agency accused of attempting to undermine autonomy of university–hospital groups.
Nature News doi: 10.1038/nature.2017.22877
The scientific and religious revolutions that began 500 years ago were not causally related, but were both stimulated by printing, argues David Wootton.
Nature 550 454 doi: 10.1038/550454a
Anthony King navigates a show on catastrophe, from nuclear apocalypse to γ-ray bursts.
Nature 550 456 doi: 10.1038/550456a
Nature 550 457 doi: 10.1038/550457a
Nature 550 457 doi: 10.1038/550457b
Nature 550 457 doi: 10.1038/550457c
Nature 550 457 doi: 10.1038/550457d
Nature 550 457 doi: 10.1038/550457e
Laser and optics pioneer whose work led to magnetic resonance imaging.
Nature 550 458 doi: 10.1038/550458a
It's the latest in travel technology.
Nature 550 554 doi: 10.1038/550554a
Top White House science job stays empty more than nine months after president took office.
Nature News doi: 10.1038/nature.2017.22878
The US Department of Energy should classify and dispose of nuclear rubbish according to risk.
Nature 550 429 doi: 10.1038/550429b
Considering game theory and the role of physical forces could lead to better treatments for cancer, says Robert Austin.
Nature 550 431 doi: 10.1038/550431a
Killing off cells that refuse to die on their own has proved a powerful anti-ageing strategy in mice. Now it's about to be tested in humans.
Nature 550 448 doi: 10.1038/550448a
The Chandrayaan-2 orbiter, lander and rover will track how lunar dust might scupper settlement.
Nature News doi: 10.1038/nature.2017.22870
Getting smaller by absorbing bone tissue may help animals to save energy when food is scarce.
Nature News doi: 10.1038/nature.2017.22874
Ahmadreza Djalali, a researcher in disaster medicine, has 20 days to appeal against his death sentence.
Nature News doi: 10.1038/nature.2017.22875
NIH Funding Opportunities
- End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional)
- End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional)
- Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional)
- NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional)
- Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed)